___

• Vincent AM, Russell JW, Low P, Feldman EL: Oxidative Stress in the Pathogenesis of Diabetic Neuropathy. Endocrine Reviews. 25: 612–628, 2004.
• Memisogullari R, Taysi S, Bakan E, Capoglu I: Antioxidant Status and Lipid Peroxidation in Type II Diabetes Mellitus. Cell Biochem Func. 21: 291-296, 2003.
• Sacks DB: Diabetes Mellitus. In: Burtis CA, Ashwood ER, (Ed). Tietz Texbook of clinical chemistry. Philadelphia: WB Saunders Co: 766- 776, 1999.
• Cherubini A, Ruggiero C, Polidori MC, Mecocci C: Potential markers of oxidative stress in stroke. Free Radical Biology & Medicine. 39: 841 – 852, 2005.
• Memişoğulları R, Bakan E: Levels of ceruloplasmin, transferrin, and lipid peroxidation in the serum of patients with Type 2 diabetes mellitus. Journal of Diabetes and Its Complications. 18: 193– 197, 2004.
• Young IS, Woodside JV. Antioxidants in health and disease. J Clin Pathol 54:176-186, (2001)
• Sözmen EY: Yaşlanma Biyokimyası. In Onat T, Emerk K, Sözmen EY (Eds) İnsan Biyokimyası, Palme Yayıncılık, Ankara pp: 665-674. 2002.
• Pratic`o D: Antioxidants and endothelium protection. Atherosclerosis. 181: 215–224, 2005.
• Alper G. Diyabet. In: Onat T, Emerk K, Sözmen EY, (eds). İnsan Biyokimyası. Ankara, Palme Yayıncılık, pp: 248-257, 2002.
• Ostenson, C. G: The pathophysiology of type 2 diabetes mellitus: an overview. Acta Physiologica Scandinavica. 171: 241– 247, 2001.
• Akçay F, Aksoy H, Memişoğulları R: Effect of breast-feeding on concentration of nitric oxide in breast milk. Ann Clin Biochem. 39: 68-69, 2002.
• Abou-Seif MA, Youssef A. Evaluation of some biochemical changes in diabetic patients. Clinica Chimica Acta 346 (2004) 161–170
• Daimon M, Hama K, Susa S, Kimura M, Yamatani K, Ohnuma H, Manaka H, Kato T. Hyperglycemia is a factor for an increase in serum ceruloplasmin in type 2 diabetes. Diabetes Care 21:1525-1528, (1998)
• Niki E, Yoshida Y, Saito Y, Noguchi N: Lipid peroxidation: Mechanisms, inhibition, and biological effects. Biochemical and Biophysical Research Communications. 338: 668–676, 2005.
• Şekeroğlu MR, Şahin H, Dülger H, Algün E: The effect of dietary treatment on erythrocyte lipid peroxidation, superoxide dismutase, glutathione peroxidase, and serum lipid peroxidation in patients with type 2 diabetes mellitus. Clin Biochem. 33:669-674, 2000.
• Masella R, Benedetto RD, Varı R, Filesi C, Giovannini C: Novel mechanisms of natural antioxidant compounds in biological systems: involvement of glutathione and glutathione- related enzymes. Journal of Nutritional Biochemistry. 16: 577–586, 2005.
• Taysi S: Oxidant/antioxidant status in liver tissue of vitamin B6 deficient rats. Clinical Nutrition. 24: 385–389, 2005.
• Memişoğulları R, Çayır K, Keleş M, Akçay F: Plasma Homocysteine and Malondialdehyde Levels in Patients with ESRD and The Effect of Hemodialysis on These Parameters. Turk J Biochem. 29 (4): 282-285, 2004.
• Ozmen B, Ozmen D, Turgan N, Habif S, Mutaf I, Bayindir O: Association between homocysteinemia and renal function in patients with type 2 diabetes mellitus. Ann Clin Lab Sci. 32:279-86, 2002.
• Rahimi R, Nikfar S, Larijani B, Abdollahi M: A review on the role of antioxidants in the management of diabetes and its complications. Biomedicine & Pharmacotherapy. 59: 365–373, 2005.
• Aydın A, Orhan H, Sayal A, Ozata M, Sahin G, Isımer A. Oxidative stress and nitric oxide related parameters in type II diabetes mellitus: effects of glycemic control. Clinical Biochemistry 34 (2001) 65–70
• Lipinski, B: Pathophysiology of oxidative stress in diabetes mellitus. Journal of Diabetes and Its Complications. 15: 203–210, 2001.
• Memişoğulları R. Plazma Homosistein Düzeyleri ile Tip 2 Diyabet, Komplikasyonları, Kontrolü ve Süresi Arasındaki Üniversitesi Tıp Fakültesi Biyokimya Anabilim Dalı, Uzmanlık Tezi, Erzurum, 2003
• Memişoğulları R, Akçay F: Hiperhomosisteinemide Biyokimyasal Mekanizmalar. Türk Klinik Biyokimya Dergisi. 2(1):41-49, 2004.
• Taysi, S., Polat, F., Gul, M., Sari, RA., Bakan, E: Lipid peroxidation, some extracellular antioxidants, and antioxidant enzymes in serum of patients with rheumatoid arthritis. Rheumatology International. 21 (5): 200–204, 2002.
• Taysi S, Gul M, Sari RA, Akcay F, Bakan N: Oxidant/antioxidant status in serum of patients with systemic lupus erythematosus. Clin Chem Lab Med. 40: 684–688, 2002.
• Habif S, Turgan N, Mutaf I, et al: Plasma catalase, glutathione peroxidase and selenium levels in adult diabetic patients. Tr J Med Sci. 27:139–141, 1997.
• Taysi S, Kocer I, Memisogullari R, Kiziltunc A: Serum oxidant/antioxidant status in patients with Behcet's disease. Ann Clin Lab Sci. 32(4):377-82, 2002.
• Komosin´ska-Vassev K, Olczyk K, Olczyk P, Winsz-Szczotka K. Effects of metabolic control and vascular complications on indices of oxidative stress in type 2 diabetic patients. Diabetes Research and Clinical Practice 68 (2005) 207–216
• Akkuş I, Kalak S, Vural H, Çağlayan O, Menekşe E, Can G, Durmuş B: Leukocyte lipid peroxidation, superoxide dismutase, glutathione peroxidase and serum and leukocyte vitamin c levels of patients with type II diabetes mellitus. Clin Chim Acta. 244:221- 227, 1996.
• Chao JC, Huang CH, Wu SJ, Yang SC, Chang NC, Shieh MJ, Lo PN: Effects of beta-carotene, vitamin C and E on antioxidant status in hyperlipidemic smokers. J Nutr Biochem. 13:427-434, 2002.
• Steinberg FM, Chait A: Antioxidant vitamin
• Bukan N, Sancak B, Bilgihan A, Kosova F, Bugdayci G, Altan N: The effects of the sulfonylurea glyburide on glutathione peroxidase, superoxide dismutase and catalase activities in the heart tissue of streptozotocin-induced diabetic rat. Methods Find Exp Clin Pharmacol. 26(7):519-22, 2004.
• Jialal I, Grundy SM: Effect of combined supplementation with alpha-tocopherol, ascorbate, and beta carotene on low-density lipoprotein oxidation. Circulation. 88: 2780-2786, 1993.
• Mamputu JC, Renier G: Advanced glycation end products increase, through a protein kinase C- dependent pathway, vascular endothelial growth factor expression in retinal endothelial cells Inhibitory effect of gliclazide. Journal of Diabetes and Its Complications. 16:284–293, 2002.
• Eijnwachter MP, Haenen GR, Bast A: Inhibition
• of human glutathione S-transferase P1-1 by
• tocopherols and alpha-tocopherol derivatives.
• Biochim Biophys Acta. 1548: 23-28, 2001.
• Singh U, Jialal I: Anti-inflammatory effects of
• Vallejo S, Angulo J, Peiro C, Sanchez-Ferrer A, Cercas E, Llergo JL, Nevado J, Sanchez-Ferrer CF, Rodrigues-Manas L: Prevention of endothelial dysfunction in streptozotocin-induced diabetic rats by gliclazide treatment. Journal of Diabetes and Its Complications, 14: 224- 233, 2000. 203, 2004.
• Alper G, Irer S, Duman E, Caglayan O, Yilmaz C: Effect of I-deprenyl and gliclazide on oxidant stress/antioxidant status and dna damage in a diabetic rat model. Endocr Res. 31(3):199-212, 2005.
• oxidative stress in the kidney and lens of streptozotocin-induced diabetic-rat. Int J Vitam Nutr Res. 2005 Jan;75(1):71-80).
• Yilmaz M, Bukan N, Ayvaz G, Karakoc A, Toruner F, Cakir N, Arslan M: The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome. Hum Reprod. 20(12):3333-40, 2005.
• Thirunavukkarasu V, Anitha Nandhini AT, Endocrine research, 27(3), 377-386 (2001)
• Will JC, Byers T: Does diabetes mellitus increase Anuradha CV: Lipoic acid improves glucose utilisation and prevents protein glycation and AGE formation. Pharmazie. 60(10):772-5, 2005. 202, 1996
• Rudich A, Tirosh A, Potashnik R, Khamaisi M, Bashan N: Lipoic acid protects against oxidative stress induced impairment in insulin stimulation of protein kinase B and glucose transport in 3T3-L1 adipocytes. Diabetologia. 42:949–957, 1999. 35:212–20, 2003.
• Maritim AC, Moore BH, Sanders RA,Watkins JB: Effects of melatonin on oxidative stress in streptozicin-induced diabetic rats. Int J Toxicol. 18:161–6, 1999.
• Desco MC, Asensi M, Marquez R, et al: Xanthine oxidase is involved in free radical production in type 1 diabetes: protection by allopurinol. Diabetes. 51(4):1118–24, 2002.
• Guerrero-Romero F, Rodrı´guez-Mora´na M: Complementary Therapies for Diabetes: The Case for Chromium, Magnesium, and Antioxidants. Archives of Medical Research. 36: 250–257, 2005.
• Radfar M, Larijani B, Hadjibabaie M, Rajabipour B, Mojtahedi A, Abdollahi M: Effects of pentoxifylline on oxidative stress and levels of EGF and NO in blood of diabetic type-2 patients:a randomized, double-blind placebo-controlled clinical trial. Biomed Pharmacother. 59(6):302-6, 2005.
• Kedziora-Kornatowska KZ, Luciak M, Paszkowski: Lipid peroxidation and activities of antioxidant enzymes in the diabetic kidney: effect of treatment with angiotensin convertase inhibitors. IUBMB Life. 49:303–7, 2000.
• Nieder C, Zimmermann FB, Adam M, Molls M. The role of pentoxifylline as a modifier of radiation therapy. Cancer Treatment Revıews. 31: 448–455, 2005.